Caitlin Pauly, MD
Dermatology · Hutchinson, KSNPI 1043553951
Payments from drug & device makers
Across 484 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$871
- Amgen$829
- Novartis$759
- Lilly USA, LLC$599
- Sun Pharmaceutical Industries Inc.$598
- plus $3K from 29 others
What the payments were for
- Food & beverage$8,63498%
- Education$1702%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 139 | $2,275 |
| Johnson & Johnson | 41 | $871 |
| Amgen | 35 | $829 |
| Novartis | 40 | $759 |
| Lilly USA, LLC | 40 | $599 |
| Sun Pharmaceutical Industries Inc. | 27 | $598 |
| Sanofi | 25 | $540 |
| Regeneron Healthcare Solutions, Inc. | 16 | $378 |
| E.r. Squibb & Sons, L.L.C. | 25 | $366 |
| UCB, Inc. | 19 | $288 |
| Pfizer | 13 | $192 |
| LEO Pharma Inc. | 8 | $145 |
| Genentech USA, Inc. | 13 | $144 |
| Bristol Myers Squibb | 8 | $111 |
| Incyte Corporation | 3 | $97 |
| Dermavant Sciences, Inc. | 4 | $69 |
| Boehringer Ingelheim | 4 | $65 |
| Sandoz | 3 | $52 |
| Galderma Laboratories, L.p. | 3 | $49 |
| Organon | 2 | $44 |
| Organogenesis Inc. | 1 | $33 |
| Biowound Solutions, Inc. | 1 | $30 |
| Paratek Pharmaceuticals, Inc. | 2 | $29 |
| VYNE Pharmaceuticals Inc. | 1 | $28 |
| Prugen, Inc. Pharmaceuticals | 1 | $26 |
| Krystal Biotech Inc | 1 | $24 |
| Smith+Nephew | 1 | $24 |
| Reprise Biomedical, Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $19 |
| Biocon Biologics Inc | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $16 |
| Merck | 1 | $14 |
| Kerecis Limited | 1 | $14 |
How this compares
$8,804 in reported general payments places this provider in the 85th percentile of 82 dermatology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 19 | $94,422 |
| Clobetasol Propionate | 94 | $4,213 |
| Fluorouracil | 28 | $1,757 |
| Tacrolimus | 19 | $1,716 |
| Ketoconazole | 68 | $1,240 |
| Triamcinolone Acetonide | 111 | $1,058 |
| Fluocinonide | 16 | $660 |
| Doxycycline Hyclate | 34 | $582 |
| Minocycline Hcl | 37 | $558 |
| Spironolactone | 25 | $535 |
| Metronidazole | 11 | $467 |
| Nystatin | 26 | $382 |
| Fluconazole | 21 | $98 |
| Cefadroxil | 11 | $92 |
| Gabapentin | 14 | $60 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hutchinson
- Stephen MarshallHutchinson$38K
- Russell KelleyHutchinson$11K
- Mark McCuneOverland Park$2M
- Anne BlakeLeawood$578K
- David KaplanOverland Park$495K
- Colin RuffLeawood$458K
- Meena SinghOverland Park$207K
- Daniel AiresKansas City$83K
- Dominic WuShawnee Mission$51K
- Kyle AndersonLeawood$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.